Development asset linked to CSL Behring in public FDA and regional records.
pharma · Oral Mucositis · Complex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring
CSL Behring GmbH
CSL Behring drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Marburg, DE HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Marburg, DE
- Programs
- 7
- Drugs
- 6
- Patents
- 25
CSL Behring pipeline
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
CSL Behring drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to CSL Behring in public FDA and regional records.
-
human heterologous liver cells
Alimentary tract and metabolism (A16)Alimentary tract and metabolism (A16) compound in CSL Behring's portfolio.
-
Development asset linked to CSL Behring in public FDA and regional records.
-
Development asset linked to CSL Behring in public FDA and regional records.
-
Development asset linked to CSL Behring in public FDA and regional records.